Skip to content

Clinical study of Shuangshi Tonglin capsules for the treatment of related diseases with symptoms of lower urinary tract irritation

Clinical study of Shuangshi Tonglin capsules for the treatment of related diseases with symptoms of lower urinary tract irritation

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071809
Enrollment
Unknown
Registered
2023-05-25
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic prostatitis, acute cystitis, acute urethritis (except gonococcal urethritis)

Interventions

Double stone tonglin capsule treatment cohort (Double stone tonglin capsules):None
Saw Palmetto fruit extract (Shabat) treatment cohort (Saw palmetto fruit extract in Shabat):None
Double stone tonglin capsule exposure cohort (Shuangshi Tonglin capsules alone or in combination with Western medicine):None
Double stone tongling capsule non-exposure cohort (Only Western medicine is used):None

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. People clinically diagnosed with chronic prostatitis, acute cystitis, urethritis (except gonococcal urethritis). 2. Symptoms of lower urinary tract irritation (frequent urination, urgency, painful urination and/or burning in the urethra) 3. The dialectic of traditional Chinese medicine is in line with the "damp heat barrier evidence" 4. Age>= 18 years old

Exclusion criteria

Exclusion criteria: Excludes urinary tract obstruction due to stones, tumors, urethral strictures/congenital malformations, and neurogenic bladder

Design outcomes

Primary

MeasureTime frame
Lower urinary tract irritation symptom score;TCM symptoms are effective at different times;

Secondary

MeasureTime frame
Disappearance rate of urinary tract irritation symptoms at different time points;Lower urinary tract irritation symptom score halved;

Countries

China

Contacts

Public ContactLi Haisong

Dongzhimen Hospital

lihs369@sina.com+86 136 0122 1399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026